Clinical Trial Update: Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV

View source ↗

Summary

This clinical trial update reports on the prevalence and factors predicting hepatic steatosis in persons living with HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: University of California, San Francisco | Conditions: NAFLD, NAFLD-HIV | Status: ACTIVE_NOT_RECRUITING